CLPT — Clearpoint Neuro Cashflow Statement
0.000.00%
Last trade - 00:00- $384.42m
- $387.57m
- $36.97m
Annual cashflow statement for Clearpoint Neuro, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14.4 | -16.4 | -22.1 | -18.9 | -25.5 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 3.24 | 4.31 | 8.1 | 7.58 | 10.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.68 | -4.29 | -0.356 | 1.4 | -9.81 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -12.7 | -16.2 | -13.7 | -8.95 | -23.9 |
| Capital Expenditures | -0.168 | -1.15 | -1.05 | -0.275 | -0.522 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -9.59 | 10 | 0 | 1.14 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.168 | -10.7 | 8.95 | -0.275 | 0.615 |
| Financing Cash Flow Items | -0.599 | -0.336 | -0.21 | -0.424 | -1.86 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 46.9 | 0.409 | 0.296 | 6.19 | 50.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 34 | -26.5 | -4.47 | -3.04 | 26.9 |